Hervycta Plus 440mg Injection

Hervycta Plus 150mg Injection contains Trastuzumab as its active ingredient and is indicated for use in HER2-positive breast cancer. In patients with HER2-positive breast cancer, the cancer cells express elevated levels of HER2 proteins that promote rapid tumour development by acting as a growth signal to malignant cells. This medication is also used to treat metastatic gastric cancer with elevated HER2 protein expression. HER2-positive breast cancers are typically more aggressive in nature. Targeted therapy for HER2-positive breast cancer works by selectively targeting the proteins responsible for cancer growth, development, and spread. Use effective contraception during treatment and for at least 7 months after the final dose. Hervycta Plus 150mg Injection is not recommended for patients under 18 years of age, or for those with severe breathing difficulties or requiring oxygen therapy. It is essential to inform your physician if you have any cardiac problems, breathlessness, or have received previous cancer treatment. Ensure you inform your physician of all medications you are taking, including supplements and herbal medicines, before beginning treatment with this medication.

Hervycta Plus 150mg Injection is indicated for its use in the following conditions: Advanced and metastatic breast cancer Metastatic gastric cancer

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth. Hervycta Plus 150mg Injection selectively binds to HER2 and stops the growth of cancer cells.

Hervycta Plus 150mg Injection shall either be administered before or after surgery. It will be given as an Intravenous infusion for 90 minutes, if well tolerated it shall be administered within 30 minutes for the next doses.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious Heart Problems Allergic reactions Kidney problems Breathing difficulties Common Fever Visual disturbances Nose bleeds or runny nose Hair loss Dizziness Nail disorders Weight loss Loss of appetite Bruising Dry mouth Liver inflammation Muscle pain Asthma/ lung disorders

It is suggested to inform your doctor if you have a history of allergic reactions to Hervycta Plus 150mg Injection to avoid life-threatening complications. If you have a history of lung disorder or breathing problems inform your doctor beforehand before the treatment commencement. Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose. Monitor your heart parameters regularly during the treatment with Hervycta Plus 150mg Injection as it may impact the functioning of heart.